Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

Amphastar Pharmaceuticals posted Q1 results last week that beat the bottom-line consensus. The stock appears cheap at under ...

While ILCG offers diversified growth exposure, its elevated volatility and lagging performance against top growth funds ...

Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...

The stock should perform well beyond 2030 thanks to its impressive innovative abilities. With a constellation of ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by ...

The Oscar-nominated actress talks about playing the activist whose 1990s lawsuit demanding equal pay with her male colleagues went all the way to the Supreme Court, and how her own mother inspired her ...